Hyperlipidemia
Conditions
Interventions
ACS subjects with uncontrolled Hyperlipidemia:NA
Sponsors
Peking University First Hospital
Eligibility
Sex/Gender
All
Age
40 Years to No maximum
Inclusion criteria
Inclusion criteria: 1. Patients who have experienced an ACS event within the past 4-40 weeks. ACS event including - hospitalization for ACS (ST-elevation MI, non-ST elevation MI or high-risk unstable angina); 2. Patients receiving active lipid lowering treatment with a stable (>2 weeks) regimen; 3. Patients' lipid level not tested after stable active lipid lowering treatment or tested but not adequately controlled indicated by a lipid test after stable active lipid lowering treatment; 4. At least 40 years of age; 5. Patient having provided written informed consent.
Exclusion criteria
Exclusion criteria: 1. Unable or unwilling to provide informed consent, including but not limited to cognitive or language barriers to comprehension; 2. Participation in any clinical trial at the time of enrollment; 3. Life expectancy <1 year.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Percentage of patients who have experienced an ACS event within the past 4-40 weeks and not achieving their respective therapeutic goal undertaking statin-intensive treatment.;Percentage of patients who have experienced an ACS event within the past 4-40 weeks and not achieving their respective therapeutic goal undertaking maximally tolerated dose of these given statins and other non-statin lipid lowering therapy if patient has documented intolerance to at least 2 statins at physician’s discretion in China.; | — |
Secondary
| Measure | Time frame |
|---|---|
| Medical reasons that limit the adoption of intensive statin treatment when patient’s therapeutic goal is not achieved.; | — |
Countries
China
Contacts
Public ContactXu CAO
Outcome results
None listed